INTRAGEL THERAPEUTICS LTD

General Data

supplementary funding
Reg Number
516293677
Sector
Biomed
Established
2020
No. of Employees
6
Stage
R&D
Additional Funding
1

Description

Intragel

Technology

Intragel is developing a unique gel-based drug delivery platform designed to administer anticancer treatments to the solid tumor locally, for enhanced efficacy with minimal side effects.

Targeted Customers

Healthcare Providers, Hospitals and Clinics, Pharmaceutical Partners, Cancer Patients.

Management personnel

Peter Siman - CEO & Co-Founder
[email protected]
Nizar Mishael - CFO
[email protected]

Contact information

Name
Nizar Mishael
Email
[email protected]
Phone
0526551384
Country
Israel
Zip
1711102

Tags

B2CCancerLife SciencesMedTechPharmaceuticals

Classified Technologies

Biomedicine and pharmaceuticals
Pharma

Winning details

Route name
Winning year

R&D Fund
R&D Fund
2024
R&D Fund
R&D Fund
2025
To the full list